** Shares of MedAdvisor MDR.AX down 5% at A$0.19
** Stock hit lowest level since Dec. 27
** Medical software co says Q2 FY25 operating revenue fell by 38.6% to A$30.8 million ($19.20 million)
** However, co expects stronger second half through diversified U.S. pipeline for various health program, others
** Stock down 11.1% this year, as of last close
($1 = 1.6044 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.